分红型重疾险离上市还有多远？

Core Viewpoint - The health insurance market is eager for innovative products, and China Ping An has announced the development of participating critical illness insurance, indicating a potential revival of "guarantee + investment" products after years of absence [1][3]. Group 1: Market Dynamics - The recent policy change in September, which allows the development of participating long-term health insurance, has cleared obstacles for the return of these products [3][6]. - Many companies are reportedly preparing to launch new participating critical illness insurance products, with expectations for market entry soon [3][4]. - The return of participating critical illness insurance is seen as a response to the declining competitiveness of traditional critical illness insurance due to falling preset interest rates [7][8]. Group 2: Product Characteristics - True participating health insurance differs fundamentally from existing products, which are often combinations of participating whole life insurance and critical illness coverage [4][5]. - Participating long-term health insurance combines coverage with the opportunity to share in the insurer's profits, potentially increasing the policy value over time to combat inflation [5][11]. - The new products are expected to enhance competitiveness in the market by offering both protection and potential value growth, appealing to consumers seeking both security and investment [7][8]. Group 3: Industry Implications - The reintroduction of participating critical illness insurance is anticipated to shift the industry from a "price war" to a "value war," focusing on long-term investment capabilities and customer service [8][11]. - The regulatory approval for these products is seen as a cautious decision based on the maturity of the market and the capabilities of insurance companies [7][10]. - The successful launch of these products will depend on several factors, including regulatory guidelines, actuarial pricing capabilities, and consumer understanding of the products [10][11].